Skip to main content
Premium Trial:

Request an Annual Quote

CareDx: Hannah Valantine

CareDx has appointed Hannah Valantine to its board of directors.

Valantine is a professor of medicine at Stanford and the former NIH CSO for Scientific Workforce Diversity. Prior to joining the NIH, she served as professor of cardiovascular medicine and senior associate dean for diversity and leadership at Stanford. Valantine has partnered with CareDx for several years, including as a principal investigator on publications for the company's AlloMap Heart test, and is one of the researchers behind the original patents for CareDx's AlloSure test.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.